URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Jonathan Friedberg

Concepts (449)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Antineoplastic Combined Chemotherapy Protocols
41
1999
409
9.430
Why?
Lymphoma, Non-Hodgkin
26
1999
105
9.030
Why?
Lymphoma, Large B-Cell, Diffuse
20
1999
72
8.060
Why?
Lymphoma, Follicular
18
1999
54
7.580
Why?
Antibodies, Monoclonal
31
2002
725
6.920
Why?
Antineoplastic Agents
26
2000
598
6.170
Why?
Antibodies, Monoclonal, Murine-Derived
35
2002
124
5.880
Why?
Hodgkin Disease
15
2002
152
3.870
Why?
Lymphoma, B-Cell
11
1999
61
3.860
Why?
Nitrogen Mustard Compounds
10
2007
17
3.450
Why?
Lymphoma, Mantle-Cell
6
2007
16
2.840
Why?
Lymphoma
8
2003
151
2.600
Why?
Drug Resistance, Neoplasm
10
2005
54
2.370
Why?
Humans
110
1981
35000
2.220
Why?
Treatment Outcome
31
1999
2487
2.210
Why?
Radioimmunotherapy
7
2004
13
2.130
Why?
Salvage Therapy
9
2007
56
2.120
Why?
Combined Modality Therapy
16
1999
459
2.100
Why?
Hematopoietic Stem Cell Transplantation
10
1999
124
1.930
Why?
Neoplasm Recurrence, Local
8
2001
272
1.740
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
4
2004
125
1.720
Why?
Neoplasms, Second Primary
6
1999
124
1.710
Why?
Boronic Acids
6
2007
25
1.700
Why?
Pyrazines
6
2007
29
1.690
Why?
Middle Aged
49
1981
9461
1.590
Why?
Protein Kinase Inhibitors
3
2009
91
1.570
Why?
Clinical Trials as Topic
14
2004
664
1.490
Why?
Oxazines
2
2009
29
1.460
Why?
Adult
46
1981
10906
1.450
Why?
Pyridines
3
2009
73
1.450
Why?
Stem Cell Transplantation
8
2006
108
1.390
Why?
Immunotherapy
5
2000
88
1.380
Why?
Intracellular Signaling Peptides and Proteins
2
2009
130
1.330
Why?
Protein-Tyrosine Kinases
2
2009
164
1.320
Why?
Survival Analysis
14
1998
575
1.270
Why?
Bone Marrow Transplantation
7
1999
189
1.260
Why?
Burkitt Lymphoma
2
2008
47
1.240
Why?
Aged
33
1981
6986
1.210
Why?
Survival Rate
15
1999
584
1.200
Why?
Male
48
1993
18870
1.170
Why?
Transplantation, Autologous
13
1999
136
1.170
Why?
Female
49
1981
19061
1.150
Why?
Recurrence
15
1998
656
1.120
Why?
Doxorubicin
7
2003
102
1.110
Why?
Deoxycytidine
4
2003
26
1.000
Why?
Medical Oncology
3
2008
40
0.990
Why?
Antigens, CD20
5
2003
26
0.980
Why?
Vidarabine
4
2004
27
0.920
Why?
Amifostine
2
2004
25
0.850
Why?
Neoplasm Staging
9
2003
326
0.830
Why?
Disease-Free Survival
11
2000
191
0.810
Why?
Protease Inhibitors
3
2007
42
0.800
Why?
Precursor Cells, B-Lymphoid
1
2012
6
0.790
Why?
Cytoprotection
2
2004
35
0.750
Why?
Histone Deacetylase Inhibitors
4
2010
25
0.740
Why?
Antibiotics, Antineoplastic
1
2011
51
0.740
Why?
Cyclophosphamide
8
1999
169
0.730
Why?
Immunologic Factors
4
2006
69
0.730
Why?
Prognosis
9
1999
1030
0.680
Why?
Heart Neoplasms
1
2009
17
0.680
Why?
B-Lymphocytes
5
2002
460
0.670
Why?
Toll-Like Receptor 9
1
2009
10
0.670
Why?
Follow-Up Studies
12
2001
1757
0.660
Why?
Heart Atria
1
2009
62
0.660
Why?
Neoplasm Proteins
2
2009
164
0.650
Why?
Gene Expression Profiling
1
2011
296
0.640
Why?
Peripheral Blood Stem Cell Transplantation
2
2003
20
0.630
Why?
Esophageal Neoplasms
1
2009
76
0.630
Why?
Cell Differentiation
2
2006
1021
0.620
Why?
Agammaglobulinemia
1
2008
16
0.620
Why?
Oligodeoxyribonucleotides
2
2004
138
0.610
Why?
B-Lymphocyte Subsets
1
2008
67
0.580
Why?
Receptors, Tumor Necrosis Factor
1
2008
130
0.560
Why?
Tomography, Emission-Computed
2
2003
30
0.560
Why?
Oligopeptides
3
2010
86
0.540
Why?
Lymphocyte Depletion
2
2002
60
0.530
Why?
Immunoglobulin G
1
2008
491
0.520
Why?
Aged, 80 and over
11
2002
2423
0.520
Why?
Drug Resistance
2
2005
97
0.520
Why?
Cohort Studies
6
1999
912
0.490
Why?
Cell Transformation, Neoplastic
2
1999
134
0.480
Why?
Clozapine
2
1993
23
0.480
Why?
Whole-Body Irradiation
2
2001
78
0.470
Why?
Eosinophilia
2
1993
31
0.470
Why?
Practice Guidelines as Topic
3
2010
288
0.470
Why?
Antibodies, Neoplasm
3
2008
39
0.470
Why?
Immunoconjugates
1
2004
9
0.460
Why?
Gallium
1
2004
5
0.460
Why?
Interferon-beta
1
2004
60
0.450
Why?
Interferon-alpha
1
2004
84
0.450
Why?
Tumor Necrosis Factor-alpha
1
2008
627
0.450
Why?
Myelodysplastic Syndromes
2
1999
129
0.440
Why?
Risk Factors
11
1993
2172
0.440
Why?
Vincristine
5
2004
57
0.400
Why?
Randomized Controlled Trials as Topic
3
2006
400
0.390
Why?
Pleural Neoplasms
1
2001
17
0.390
Why?
Neoplasms
2
2005
701
0.380
Why?
Tympanoplasty
1
2001
2
0.380
Why?
Mesothelioma
1
2001
30
0.380
Why?
Adenoidectomy
1
2001
10
0.380
Why?
Pneumonia
1
2003
188
0.380
Why?
Tonsillectomy
1
2001
15
0.380
Why?
Interleukin-2
1
2002
198
0.380
Why?
Prednisone
5
2004
178
0.370
Why?
United States
9
2004
2511
0.370
Why?
Guideline Adherence
2
2010
72
0.370
Why?
Trans-Activators
1
2004
343
0.370
Why?
Lymphoma, B-Cell, Marginal Zone
3
2005
10
0.360
Why?
Photochemotherapy
1
2001
97
0.360
Why?
Thalidomide
2
2010
13
0.360
Why?
Drug Synergism
5
2009
149
0.350
Why?
Proteasome Endopeptidase Complex
2
2008
65
0.350
Why?
Cytarabine
3
2004
82
0.340
Why?
Somatostatin
1
1999
79
0.330
Why?
Signal Transduction
6
2005
1465
0.330
Why?
Drug Administration Schedule
4
2002
362
0.330
Why?
Vinblastine
3
2003
27
0.330
Why?
Antibodies, Monoclonal, Humanized
2
2008
89
0.330
Why?
Vitamin D
2
2009
64
0.330
Why?
Sarcoma
1
1999
59
0.330
Why?
DNA-Binding Proteins
1
2004
661
0.320
Why?
Otitis Media
1
2001
127
0.320
Why?
Ultraviolet Rays
2
2009
191
0.320
Why?
Incidence
6
1993
644
0.320
Why?
Melphalan
2
2004
27
0.310
Why?
Neoplasms, Radiation-Induced
2
2008
80
0.310
Why?
Carmustine
2
2004
35
0.300
Why?
Etoposide
2
2004
73
0.300
Why?
Depressive Disorder
2
1993
307
0.280
Why?
Antidepressive Agents
1
1998
88
0.280
Why?
T-Lymphocytes
3
2002
546
0.280
Why?
Dose-Response Relationship, Drug
4
1999
1085
0.270
Why?
Child
8
1981
3897
0.270
Why?
Retrospective Studies
6
1994
2167
0.260
Why?
Apoptosis
4
2005
782
0.260
Why?
Remission Induction
5
2001
155
0.250
Why?
Colitis
1
1995
24
0.250
Why?
Antineoplastic Agents, Alkylating
3
1999
38
0.250
Why?
Polymerase Chain Reaction
3
1999
586
0.240
Why?
Diagnostic Imaging
2
2010
81
0.230
Why?
Branchial Region
1
1993
4
0.230
Why?
Registries
2
2008
203
0.230
Why?
Antipsychotic Agents
1
1995
96
0.230
Why?
Antibody-Dependent Cell Cytotoxicity
2
2002
28
0.220
Why?
Kaplan-Meier Estimate
2
2011
190
0.220
Why?
Bronchi
1
1994
91
0.220
Why?
Trachea
1
1994
67
0.220
Why?
Hydroxamic Acids
2
2010
19
0.220
Why?
Young Adult
4
2009
1013
0.220
Why?
Esophagus
1
1994
69
0.220
Why?
Foreign Bodies
1
1994
46
0.220
Why?
Psychotic Disorders
1
1993
50
0.220
Why?
Extracellular Signal-Regulated MAP Kinases
2
2010
39
0.220
Why?
Adolescent
8
1981
4513
0.220
Why?
Flow Cytometry
2
2004
597
0.220
Why?
Age Factors
3
2001
1060
0.220
Why?
Hospitals, County
1
1992
1
0.210
Why?
Hospitals, General
1
1992
17
0.210
Why?
Immunophenotyping
3
2002
123
0.210
Why?
Cancer Vaccines
2
2007
31
0.210
Why?
Graft vs Host Disease
2
2002
92
0.200
Why?
Germinal Center
1
2012
16
0.200
Why?
Mitoxantrone
2
2004
20
0.200
Why?
Proto-Oncogene Proteins c-bcl-2
2
2009
110
0.200
Why?
Positron-Emission Tomography
2
2008
35
0.200
Why?
Pyrroles
1
2012
19
0.200
Why?
Postoperative Complications
2
2001
706
0.200
Why?
JNK Mitogen-Activated Protein Kinases
2
2009
83
0.200
Why?
Cell Separation
2
2002
224
0.200
Why?
Tumor Microenvironment
1
2011
12
0.200
Why?
Pneumocystis jirovecii
1
2011
4
0.190
Why?
Central Nervous System Neoplasms
1
2011
20
0.190
Why?
Infant
5
1981
2102
0.190
Why?
Hispanic Americans
1
2012
86
0.190
Why?
Molecular Targeted Therapy
1
2011
20
0.190
Why?
Interleukin-10
1
2012
99
0.190
Why?
Referral and Consultation
2
1994
188
0.190
Why?
Methylprednisolone
1
2011
44
0.190
Why?
Disease Progression
2
2003
496
0.190
Why?
Gastrointestinal Tract
1
2011
26
0.190
Why?
Patient Selection
2
2007
197
0.190
Why?
Databases, Factual
1
2012
147
0.190
Why?
Child, Preschool
6
1981
2452
0.190
Why?
Pancytopenia
1
2010
13
0.180
Why?
Maximum Tolerated Dose
1
2010
16
0.180
Why?
Radiology
1
2011
29
0.180
Why?
Mucositis
1
2010
13
0.180
Why?
Transplantation Conditioning
1
2010
33
0.180
Why?
Acute Disease
2
1993
570
0.180
Why?
Healthcare Disparities
1
2012
72
0.180
Why?
Arabinonucleosides
1
2010
2
0.180
Why?
Waldenstrom Macroglobulinemia
1
2010
5
0.180
Why?
Immunoglobulin kappa-Chains
1
2010
31
0.180
Why?
Genes, Immunoglobulin
1
2010
38
0.180
Why?
Adenine Nucleotides
1
2010
35
0.180
Why?
Immunoglobulin Heavy Chains
1
2010
45
0.180
Why?
Transplantation, Homologous
2
2002
261
0.180
Why?
Pneumonia, Pneumocystis
1
2011
118
0.180
Why?
European Continental Ancestry Group
1
2012
225
0.170
Why?
Esophagogastric Junction
1
2009
8
0.170
Why?
MAP Kinase Kinase Kinases
1
2010
38
0.170
Why?
Glucocorticoids
1
2011
159
0.170
Why?
African Americans
1
2012
209
0.170
Why?
Diarrhea
1
2009
61
0.170
Why?
Hematologic Diseases
1
2009
40
0.170
Why?
Protein Kinase C
1
2011
193
0.170
Why?
Comorbidity
2
2005
365
0.170
Why?
Drug Therapy, Combination
2
1999
375
0.170
Why?
Endoscopy, Gastrointestinal
1
2009
24
0.170
Why?
Chemokine CXCL10
1
2009
23
0.170
Why?
Antigens, CD
2
2002
240
0.170
Why?
Benzopyrans
1
2009
7
0.170
Why?
Forecasting
1
2010
172
0.170
Why?
Vitamin D Deficiency
1
2009
31
0.170
Why?
Multiple Myeloma
1
2010
73
0.170
Why?
Fatal Outcome
1
2009
101
0.170
Why?
Platinum Compounds
1
2009
7
0.170
Why?
Atrial Fibrillation
1
2010
110
0.170
Why?
Nitriles
1
2009
39
0.160
Why?
Time Factors
4
2004
3047
0.160
Why?
Predictive Value of Tests
3
2003
579
0.160
Why?
Phosphatidylinositol 3-Kinases
1
2010
133
0.160
Why?
Chemotherapy, Adjuvant
1
2009
85
0.160
Why?
Radiotherapy, Adjuvant
1
2009
72
0.160
Why?
Research Personnel
1
2008
15
0.160
Why?
Daunorubicin
1
2008
25
0.160
Why?
Cancer Care Facilities
1
2008
10
0.160
Why?
Databases as Topic
1
2008
32
0.160
Why?
SEER Program
1
2009
51
0.160
Why?
Gene Expression Regulation, Neoplastic
1
2011
247
0.160
Why?
Echocardiography
1
2009
202
0.160
Why?
Endoplasmic Reticulum
1
2009
89
0.160
Why?
Breast Neoplasms
2
2002
660
0.160
Why?
Yttrium Radioisotopes
1
2008
1
0.160
Why?
Bone Marrow Purging
1
2008
4
0.150
Why?
Immunoglobulin Class Switching
1
2008
23
0.150
Why?
Drugs, Investigational
1
2008
8
0.150
Why?
Graft Survival
3
2002
145
0.150
Why?
Chemokine CCL2
1
2009
124
0.150
Why?
Italy
1
2008
22
0.150
Why?
Sinusitis
1
2008
23
0.150
Why?
Myeloid Cells
1
2008
15
0.150
Why?
Antibody Formation
1
2009
176
0.150
Why?
Cell Line, Tumor
4
2009
543
0.150
Why?
Cytogenetics
1
2008
14
0.150
Why?
National Cancer Institute (U.S.)
1
2008
11
0.150
Why?
Drug Monitoring
1
2008
39
0.150
Why?
Immunoglobulins, Intravenous
1
2008
38
0.150
Why?
Genes, myc
1
2008
26
0.150
Why?
Biopsy, Fine-Needle
1
2008
21
0.150
Why?
CD4 Lymphocyte Count
1
2008
147
0.150
Why?
HIV Seropositivity
1
2008
32
0.150
Why?
Epitopes
1
2008
200
0.150
Why?
Health Status Indicators
1
2008
97
0.150
Why?
Pyrimidines
1
2008
64
0.150
Why?
Radiotherapy Dosage
1
2008
185
0.150
Why?
Piperazines
1
2008
71
0.150
Why?
Data Collection
1
2008
201
0.150
Why?
Bleomycin
2
2003
44
0.150
Why?
Immunocompromised Host
1
2008
84
0.150
Why?
Drug Delivery Systems
1
2008
59
0.150
Why?
Gene Rearrangement
2
2002
38
0.150
Why?
In Situ Hybridization, Fluorescence
1
2008
107
0.150
Why?
Interferon-gamma
1
2009
340
0.140
Why?
Leukemia, Myeloid
1
2008
115
0.140
Why?
Introns
1
2008
112
0.140
Why?
Tumor Markers, Biological
1
2009
221
0.140
Why?
Immunologic Memory
1
2008
132
0.140
Why?
Time
1
2006
44
0.140
Why?
Liver
1
2011
870
0.140
Why?
Leukemia, Myeloid, Acute
1
2008
172
0.140
Why?
Mice, Nude
3
2010
178
0.140
Why?
Radiotherapy
1
2008
179
0.140
Why?
Proteins
1
2009
435
0.130
Why?
Hypertension
1
2009
285
0.130
Why?
Psittacosis
1
2005
2
0.130
Why?
Chlamydophila psittaci
1
2005
3
0.130
Why?
Eye Neoplasms
1
2005
19
0.130
Why?
Brain Neoplasms
1
2008
254
0.130
Why?
Immunohistochemistry
1
2009
1024
0.130
Why?
Molecular Biology
1
2006
45
0.130
Why?
Cell Division
1
2008
735
0.130
Why?
Complement C1q
1
2005
8
0.120
Why?
Hospitalization
2
1993
354
0.120
Why?
Promoter Regions, Genetic
1
2008
534
0.120
Why?
STAT1 Transcription Factor
1
2004
21
0.110
Why?
Neoplastic Cells, Circulating
1
2003
7
0.110
Why?
Prospective Studies
4
2002
1606
0.110
Why?
Iodine Radioisotopes
1
2004
98
0.110
Why?
Magnetic Resonance Imaging
1
2009
928
0.110
Why?
Blood Component Removal
1
2003
11
0.110
Why?
Risk
2
2001
343
0.110
Why?
Cause of Death
2
2001
155
0.110
Why?
Random Allocation
1
2004
245
0.110
Why?
Schizophrenia
2
1993
95
0.110
Why?
Infusions, Intravenous
1
2003
139
0.110
Why?
Proportional Hazards Models
2
2001
398
0.110
Why?
Administration, Oral
1
2004
302
0.110
Why?
Fluorine Radioisotopes
1
2003
8
0.110
Why?
Fluorodeoxyglucose F18
1
2003
17
0.110
Why?
Radiopharmaceuticals
1
2003
48
0.110
Why?
Chromosomes, Human, Pair 14
1
2002
16
0.100
Why?
Chromosomes, Human, Pair 18
1
2002
15
0.100
Why?
Antigens, CD56
1
2002
16
0.100
Why?
Eosinophils
1
2002
46
0.100
Why?
Histocompatibility
1
2002
14
0.100
Why?
Lymphoma, T-Cell
1
2002
10
0.100
Why?
Breast Implants
1
2002
12
0.100
Why?
MAP Kinase Kinase 4
2
2011
23
0.100
Why?
Analysis of Variance
2
1998
705
0.100
Why?
Pneumonectomy
1
2001
13
0.100
Why?
Pleural Effusion
1
2001
29
0.100
Why?
Positive-Pressure Respiration
1
2001
26
0.100
Why?
Epidemiologic Methods
1
2001
55
0.100
Why?
Biological Markers
1
2004
532
0.100
Why?
Ontario
1
2001
10
0.100
Why?
Lymph Node Excision
1
2001
45
0.100
Why?
Risk Assessment
2
1999
808
0.090
Why?
Laser Therapy
1
2001
62
0.090
Why?
Radiation-Sensitizing Agents
1
2001
72
0.090
Why?
Tongue Neoplasms
1
1981
6
0.090
Why?
Thyroglossal Cyst
1
1981
6
0.090
Why?
Xenograft Model Antitumor Assays
2
2010
43
0.090
Why?
Choristoma
1
1981
19
0.090
Why?
Gene Expression
1
2004
723
0.090
Why?
Thyroid Gland
1
1981
51
0.090
Why?
Reoperation
1
2001
182
0.090
Why?
Sensitivity and Specificity
1
2004
866
0.090
Why?
CD8-Positive T-Lymphocytes
1
2002
223
0.090
Why?
Octreotide
1
1999
5
0.090
Why?
Indium Radioisotopes
1
1999
4
0.090
Why?
Abdominal Neoplasms
1
1999
14
0.090
Why?
Chondrosarcoma
1
1999
12
0.090
Why?
Sarcoma, Synovial
1
1999
7
0.090
Why?
Thigh
1
1999
22
0.090
Why?
Hematopoietic Stem Cells
1
2002
196
0.080
Why?
Medical Records
2
2008
122
0.080
Why?
Karyotyping
1
1999
107
0.080
Why?
Histones
2
2011
170
0.080
Why?
Tomography, Emission-Computed, Single-Photon
1
1999
65
0.080
Why?
Enzyme Activation
2
2009
511
0.080
Why?
Liver Neoplasms
1
1999
149
0.080
Why?
Bone Neoplasms
1
1999
180
0.080
Why?
Enzyme Inhibitors
2
2009
396
0.070
Why?
Statistics, Nonparametric
1
1998
251
0.070
Why?
Lung Neoplasms
1
1999
422
0.070
Why?
Mice
3
2010
5900
0.060
Why?
Reproducibility of Results
2
2008
859
0.060
Why?
Logistic Models
2
2004
581
0.060
Why?
Respiratory Sounds
1
1994
22
0.060
Why?
Bronchoscopy
1
1994
27
0.060
Why?
Esophagoscopy
1
1994
28
0.060
Why?
Infant, Newborn
2
1981
1772
0.060
Why?
Posture
1
1994
107
0.060
Why?
Patient Admission
1
1994
77
0.060
Why?
Leukocyte Count
1
1993
152
0.060
Why?
Syndrome
1
1993
203
0.050
Why?
Catheterization
1
1994
122
0.050
Why?
Wisconsin
1
1992
8
0.050
Why?
Lung
1
1999
1132
0.050
Why?
Length of Stay
1
1994
284
0.050
Why?
Neoplasm Grading
1
2012
8
0.050
Why?
bcl-2 Homologous Antagonist-Killer Protein
1
2012
2
0.050
Why?
Receptors, Antigen, B-Cell
1
2012
17
0.050
Why?
Watchful Waiting
1
2012
2
0.050
Why?
Anthracyclines
1
2012
17
0.050
Why?
Apoptosis Regulatory Proteins
1
2012
20
0.050
Why?
bcl-2-Associated X Protein
1
2012
52
0.050
Why?
Drug Evaluation
1
2011
98
0.050
Why?
Cell Cycle Checkpoints
1
2011
3
0.050
Why?
Oncogene Protein v-akt
1
2011
5
0.050
Why?
Sex Factors
1
1993
561
0.050
Why?
Injections, Intra-Arterial
1
2011
29
0.050
Why?
Histone Deacetylases
1
2012
70
0.050
Why?
History, 20th Century
1
1992
232
0.050
Why?
Proto-Oncogene Proteins c-akt
1
2012
114
0.050
Why?
Protein Kinases
1
2012
110
0.050
Why?
Population Surveillance
1
2012
120
0.050
Why?
Superoxide Dismutase
1
2011
73
0.050
Why?
Leukopenia
1
2010
24
0.050
Why?
Diagnosis, Differential
1
1994
855
0.050
Why?
Caspases
1
2011
98
0.050
Why?
Reed-Sternberg Cells
1
2010
5
0.050
Why?
Microdissection
1
2010
8
0.050
Why?
Paraffin Embedding
1
2010
13
0.050
Why?
Formaldehyde
1
2010
24
0.040
Why?
Tissue Fixation
1
2010
19
0.040
Why?
Disease Management
1
2010
26
0.040
Why?
Chymotrypsin
1
2010
8
0.040
Why?
Animals
3
2010
15647
0.040
Why?
Multicenter Studies as Topic
1
2010
126
0.040
Why?
Anemia
1
2010
76
0.040
Why?
Benzenesulfonates
1
2010
7
0.040
Why?
DNA, Neoplasm
1
2010
127
0.040
Why?
Benzamides
1
2010
18
0.040
Why?
Societies, Medical
1
2011
132
0.040
Why?
Calcifediol
1
2009
6
0.040
Why?
Clone Cells
1
2010
188
0.040
Why?
Dihydroxycholecalciferols
1
2009
9
0.040
Why?
Nutrition Policy
1
2009
11
0.040
Why?
Proto-Oncogene Proteins
1
2012
261
0.040
Why?
Seasons
1
2009
92
0.040
Why?
Dietary Supplements
1
2009
43
0.040
Why?
Physician's Practice Patterns
1
2012
223
0.040
Why?
Nausea
1
2010
153
0.040
Why?
Lymphoproliferative Disorders
1
2009
30
0.040
Why?
Protein Binding
1
2012
812
0.040
Why?
DNA Damage
1
2010
168
0.040
Why?
Cladribine
1
2008
6
0.040
Why?
Blast Crisis
1
2008
20
0.040
Why?
Cell Cycle
1
2010
247
0.040
Why?
Immunity, Cellular
1
2009
135
0.040
Why?
Phosphorylation
1
2011
754
0.040
Why?
Granulocyte Colony-Stimulating Factor
1
2008
42
0.040
Why?
Observer Variation
1
2008
137
0.040
Why?
Multivariate Analysis
1
2010
487
0.040
Why?
Case-Control Studies
1
2010
587
0.040
Why?
Membrane Proteins
1
2012
530
0.040
Why?
Evidence-Based Medicine
1
2009
197
0.040
Why?
Tomography, X-Ray Computed
1
2012
729
0.040
Why?
Blotting, Western
1
2010
617
0.040
Why?
Antibodies, Anti-Idiotypic
1
2007
54
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
513
0.040
Why?
Severity of Illness Index
1
2011
878
0.040
Why?
Dacarbazine
1
2007
17
0.040
Why?
Polyethylene Glycols
1
2007
56
0.040
Why?
Bone Marrow
1
2008
282
0.030
Why?
Mitochondria
1
2010
337
0.030
Why?
Transfection
1
2010
833
0.030
Why?
Neutropenia
1
2007
61
0.030
Why?
Thrombocytopenia
1
2007
71
0.030
Why?
NF-kappa B
1
2010
405
0.030
Why?
DNA, Bacterial
1
2005
167
0.030
Why?
Prednisolone
1
2004
24
0.030
Why?
Radiation-Protective Agents
1
2004
38
0.030
Why?
Cytokines
1
2007
555
0.030
Why?
Chi-Square Distribution
1
2004
320
0.030
Why?
Bone Marrow Cells
1
2004
220
0.030
Why?
Radiotherapy, High-Energy
1
2002
22
0.030
Why?
Dose-Response Relationship, Radiation
1
2002
205
0.020
Why?
Silicone Gels
1
2002
8
0.020
Why?
Hematopoietic Stem Cell Mobilization
1
2002
14
0.020
Why?
Microspheres
1
2002
53
0.020
Why?
Tissue Donors
1
2002
69
0.020
Why?
Antigens, Differentiation, B-Lymphocyte
1
2002
51
0.020
Why?
Hyoid Bone
1
1981
5
0.020
Why?
Mediastinal Neoplasms
1
1981
21
0.020
Why?
Survivors
1
2002
112
0.020
Why?
Pilot Projects
1
2002
426
0.020
Why?

Visualizations


Friedberg's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department